REYON Pharmaceutical Co., Ltd. (KRX:102460)
10,560
-440 (-4.00%)
At close: Mar 3, 2026
-16.78% (1Y)
| Market Cap | 201.75B |
| Revenue (ttm) | 149.34B |
| Net Income (ttm) | -14.25B |
| Shares Out | 18.34M |
| EPS (ttm) | -773.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 89,644 |
| Average Volume | 78,460 |
| Open | 10,900 |
| Previous Close | 11,000 |
| Day's Range | 10,560 - 10,950 |
| 52-Week Range | 9,830 - 14,430 |
| Beta | 0.57 |
| RSI | 42.28 |
| Earnings Date | Feb 13, 2026 |